Sign in Check my fit
EN
Home / Horizon Europe / HORIZON-HLTH-2027-02-DISEASE-01-two-stage

Innovative healthcare interventions for non-communicable diseases

Announced, not yet open · HORIZON Research and Innovation Actions · two-stage · HORIZON-HLTH-2027-02-DISEASE-01-two-stage

Next cut-off
13 Apr '27
in 219 days
Per grant
€8.0M
the call's own average
Grants expected
8
projects that will be funded
Funding rate
100%
the full cost of the action

In context of Horizon Europe

This grant€8.0M
The track runs to the largest grant in Horizon Europe (€171M). The median across the 482 calls we publish is €5.3M, this one is above it.

What this call funds

Expected Outcome:

This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:

  • Researchers, developers and clinical practitioners have access to state-of-the-art knowledge, data, technologies, tools, methods, best practices, and trainings to develop innovative healthcare interventions aimed at reducing burden of the following specific Non-Communicable Diseases (NCDs): cardiovascular diseases, diabetes, chronic respiratory diseases or chronic kidney diseases.
  • Scientific and clinical communities can use innovative healthcare interventions to generate meaningful advances in clinical practice and care for patients with NCDs following validation in late-stage clinical trials.
  • Scientific and clinical communities make wide use of relevant databases and/or integrate them with existing infrastructures for storage and sharing of collected data according to FAIR[1] principles, thereby encouraging further use of the data.
  • Policymakers, scientific and clinical communities, developers, patient organisations, regulators, and other relevant bodies are informed of the research advances made and the requirements for a widespread implementation of the innovative therapeutic interventions and complementary approaches.
  • Patients and caregivers are constructively engaged with the research, ensuring that their needs are catered for, with the aim of tangibly benefitting from the interventions.

Scope:

Trimmed here, the full scope, expected outcomes and award criteria are on the official topic page ↗.

Cut-offs

Later cut-off22 Sept 2027

What applying costs you

ItemEstimateNote
Drafting effort8–10 weeksshort proposal, then a full one
Partner search4–8 weeksruns in parallel, and it is the part that slips
Time to first payment9–12 monthscut-off → evaluation → grant agreement

These are Bemzu's estimates from the call's structure (the number of stages and whether a consortium is required) not figures published by the Commission. Only the co-financing share is read from the call itself.

Where these conditions come from

Two kinds of row. Most are the sentence we read the condition from, quoted out of the call itself. Some say plainly that they are not a quotation but the programme's own rule for this type of action, the EU portal publishes a table of contents where the conditions should be, so for a Research and Innovation Action the rate comes from the rulebook rather than from the fiche.

ConditionQuoted from the call, or the rule behind it
Consortium sizeNot quoted from this call — Research and Innovation Actions under the Horizon Europe rules are at least three independent legal entities from three different Member States or Associated Countries, at least one established in a Member State.
Funding rateNot quoted from this call — Research and Innovation Actions under the Horizon Europe rules are funded at 100% of eligible costs for every participant.

Also open in HE

Become the beneficiary.

Eight questions, no account, nothing sent anywhere. You will know which of the 1526 open calls you can actually enter before you finish your coffee.

Check my fit